Dr. Gregory Robert Thoreson, MD

Dr. Thoreson practices at Urology Clinics of North Texas in Dallas, Texas.

Dr. Thoreson's NPI, 1093034126, was assigned on May 28, 2010. Dr. Thoreson graduated from Joe R. & Teresa Lozano Long School of Medicine in 2010. Dr. Thoreson holds Texas license Q4316.

Dr. Thoreson's primary practice is Urology Clinics of North Texas, at 9900 N Central Expy, Dallas, TX 75231 in Dallas County. The practice phone is (214) 691-1902.

Dr. Thoreson's primary practice is Urology Clinics of North Texas in Dallas, Texas. Dr. Thoreson is also affiliated with Baylor University Medical Center. The medical group on file is Urology Clinics of North Texas. Dmand AI also links Dr. Thoreson to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thoreson practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Thoreson's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Thoreson is board certified in urology by the American Board of Urology. Dr. Thoreson is licensed in Texas.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney disease, kidney removal surgery and kidney stone disease among the conditions Dr. Thoreson treats.

CMS data shows 4,590 Medicare services from Dr. Thoreson across 36 procedure codes in 2024, for 664 Medicare patients. Medicare paid $215,224 for them.

CMS counts 664 Medicare patients who saw Dr. Thoreson in 2024. The largest group is 65 to 74, with 319 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thoreson's median patient age at 64, with 16% women.

In 2024, Dr. Thoreson wrote 2,526 Medicare Part D claims for 559 patients. 81% of them were for generic drugs. CMS names the drug for 2,374 of them, across 28 drugs with 11 or more claims each, at $807,561 in total drug cost. In 2023, CMS named 1,760 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Thoreson for performance year 2024, reported as part of a group. Dr. Thoreson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thoreson as offering telehealth. CMS counts 12 procedures of prostate resection by Dr. Thoreson, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Thoreson, published from 2013 to 2025. 2015 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Biopsy and Kidney Neoplasms. Dr. Thoreson has published most often in J Urol. Dr. Thoreson's most frequent co-authors are Alexander Chow, MD, Scott Egon Eggener and Bishoy A. Gayed, MD.

Dmand AI links Dr. Thoreson to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Non-Muscle Invasive Bladder Neoplasms and Urinary Bladder Neoplasms.

CMS Open Payments shows 550 general payments to Dr. Thoreson from 61 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 40% of the total. Intuitive Surgical, Inc. paid the most, $7,089.

Dr. Thoreson graduated from Joe R. & Teresa Lozano Long School of Medicine in 2010.

Dr. Thoreson is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.